DVx Inc.

Tokyo Stock Exchange 3079.T

DVx Inc. Capital Expenditure for the year ending March 31, 2024: USD -1.96 M

DVx Inc. Capital Expenditure is USD -1.96 M for the year ending March 31, 2024, a -3.67% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

DVx Inc. Capital Expenditure for the year ending March 31, 2023 was USD -1.89 M, a -101.36% change year over year.
DVx Inc. Capital Expenditure for the year ending March 31, 2022 was USD -939.01 K, a 58.11% change year over year.
DVx Inc. Capital Expenditure for the year ending March 31, 2021 was USD -2.24 M, a 35.64% change year over year.
DVx Inc. Capital Expenditure for the year ending March 31, 2020 was USD -3.48 M, a -121.62% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

Tokyo Stock Exchange: 3079.T

DVx Inc.

CEO	Mr. Hiroshi Shibasaki
IPO Date	April 25, 2007
Location	Japan
Headquarters	Mejiro Nakano Building
Employees	316
Sector	Healthcare
Industries Medical Instruments 3D Printing Biotechnology Hardware & Electronics

Description

DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. The company sells arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters. It also offers ischemia-related products, including excimer laser systems; RADPAD, which reduces scatter radiation exposure to medical personnel during fluoroscopy procedures; RADNEK that reduces scatter radiation exposure to the thyroid in medical personnel during fluoroscopy procedures; RADCAP, which reduces scatter radiation exposure to the head of medical personnel during fluoroscopy procedures; and resolution/resolution SD and wonder belt products. In addition, the company engages in the research, development, manufacture, sale, repair, and leasing of medical devices and related peripheral devices; provision of internal and external medical and medical device-related general consulting and services; and medical publishing and market research activities. DVx Inc. was founded in 1986 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years